Rare diseases
Investigational molecules
Locations
Avinguda Meridiana 358 6 Planta, 08027 Barcelona, Spain
Research activity centers on non-small cell lung cancer (NSCLC), including unresectable, resectable, and completely resected disease, with attention to locally advanced and thoracic-confined tumors. The portfolio also includes ALK-positive and KRAS p.G12C disease, as well as upper-lobe and Pancoast presentations.
Clinical interests include perioperative, adjuvant, and maintenance therapy settings, with outcomes focused on progression-free survival, disease-free survival, and pathological complete response.
Fundacion GECP runs clinical trials in conditions such as Non-small cell lung cancer, Small cell lung cancer limited stage, Non-small cell lung cancer stage IV, Small cell lung cancer extensive stage, among others.
Clinical trials run by this sponsor – those enrolling participants first.
SpainSpainSpainSpainSpainSpainSpainSpainSpainSpainSpainSpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
